PLATINUM INVESTMENT MANAGEMENT LTD
Position in ARWR — Arrowhead Pharmaceuticals, Inc.
CIK 1256071
SYDNEY AUSTRALIA 2000, C3
Position in ARWR
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$4,059,950
-$1,880,892 QoQ
Shares Held
64,752
-27.6% QoQ
Ownership
0.046%
of shares outstanding
% of Portfolio
1.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2023
13 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ARWR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PLATINUM INVESTMENT MANAGEMENT LTD holds $70,718,725 across 29 Biotechnology names. ARWR ranks #7 (5.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TERN |
Terns Pharmaceuticals, Inc.
|
110,734 | $5,837,896 | |
| 2 | CNTA |
Centessa Pharmaceuticals plc
|
137,741 | $5,471,072 | |
| 3 | APGE |
Apogee Therapeutics, Inc.
|
58,314 | $4,908,289 | |
| 4 | VERA |
Vera Therapeutics, Inc.
|
113,687 | $4,573,628 | |
| 5 | IMVT |
Immunovant, Inc.
|
181,774 | $4,515,266 | |
| 6 | COGT |
Cogent Biosciences, Inc.
|
112,066 | $4,313,420 | |
| 7 | ARWR |
Arrowhead Pharmaceuticals, Inc.
This page
|
64,752 | $4,059,950 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
49,269 | $3,658,715 |
All Filings in ARWR
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,059,950 | 64,752 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $5,940,842 | 89,484 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $3,829,148 | 111,022 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,754,147 | 111,022 | Shares | Sole | 2025-07-21 | |
| 2025-03-31 | $1,253,730 | 98,409 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,662,390 | 88,425 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $1,712,792 | 88,425 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $2,298,165 | 88,425 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $2,779,004 | 97,168 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $2,973,340 | 97,168 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $2,610,904 | 97,168 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $3,465,010 | 97,168 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $1,935,683 | 76,208 | Shares | Sole | 2023-05-12 | |
| No filing history on record for this holder in this stock. | ||||||